Regenerative Patch Technologies, LLC

Call
Website
150 Gabarda Way
Portola Valley, CA 94028
+1 (650) 394-5835
https://regenerativepatch.com

Regenerative Patch Technologies, LLC (RPT) is a biotechnology company based in Portola Valley, California, specializing in the development of cell-based implant technology aimed at treating retinal diseases. The company is currently advancing its lead product, a polarized monolayer of human embryonic stem cell-derived retinal pigment epithelium, through clinical trials for patients with geographic atrophy, a severe form of age-related macular degeneration.

In July 2023, RPT received a significant boost with a $12.4 million grant from the California Institute for Regenerative Medicine to support a Phase 2b clinical trial, highlighting the urgency and importance of finding effective treatments for a condition affecting millions worldwide. The company is dedicated to promoting retinal health and potentially improving vision outcomes for patients suffering from impaired vision.

Generated from the website

Also at this address

Own this business?
See a problem?

You might also like

HepaTx Corporation

HepaTx Corporation, based in Palo Alto, CA, is focused on developing off-the-shelf cell therapies for liver disease, utilizing advanced regenerative medicine technologies. With over 30 million Americans affected by liver disease and only a fraction able to receive necessary transplants, HepaTx aims to provide innovative treatment alternatives to improve patient outcomes. The company prides itself on its scalable manufacturing processes and a curated team of experts dedicated to revolutionizing liver care. By fostering collaboration with entrepreneurial pioneers and distinguished investors, HepaTx is committed to educating the public on accessible alternatives to liver transplantation. Generated from the website

Auransa

Auransa is a clinical stage biopharmaceutical company based in Palo Alto, California, that utilizes a proprietary AI platform to harness human disease data for the discovery of novel therapeutics. Focused on raising the standard of cancer care, the company aims to develop targeted treatments by analyzing extensive gene expression profiles across various diseases. With a strong emphasis on precision medicine, Auransa's innovative approach integrates advanced data science with biological discovery, enabling it to pioneer new therapies for conditions such as liver cancer. Founded by industry veterans, the company is committed to improving patient outcomes through its AI-driven solutions. Generated from the website

Augmenta Bioworks

Augmenta Bioworks, located in Menlo Park, CA, is dedicated to building global immunity to disease by discovering new therapeutics that harness the power of natural human immunity. Their technology identifies specific immune responses and translates these findings into therapies that can benefit the broader population. Utilizing advanced methods such as automation, microfluidics, high-throughput DNA sequencing, and scalable computational analysis, Augmenta facilitates the discovery of immune receptors and their antigen specificity. Collaborating with pharmaceutical and biotechnology companies, as well as research institutions, they aim to revolutionize approaches to vaccine development, immune engineering, antibody discovery, and cell therapy. Generated from the website
United States›California›Portola Valley›Regenerative Patch Technologies, LLC

Partial Data by Infogroup (c) 2024. All rights reserved.